- Home
- ALDX vs LWAY Comparison
ALDX vs LWAY Comparison
Compare ALDX & LWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALDX | LWAY |
|---|---|---|
| Founded | 2004 | 1986 |
| Country | United States | United States |
| Employees | 8 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 317.7M | 347.2M |
| IPO Year | 2014 | 1987 |
Fundamental Metrics
Financial Performance| Metric | ALDX | LWAY |
|---|---|---|
| Price | $5.15 | $21.78 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $9.50 | ★ $35.00 |
| AVG Volume (30 Days) | ★ 829.3K | 48.1K |
| Earning Date | 03-02-2026 | 03-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.74 |
| Revenue | N/A | ★ $204,069,000.00 |
| Revenue This Year | N/A | $15.23 |
| Revenue Next Year | $36.25 | $13.72 |
| P/E Ratio | ★ N/A | $29.76 |
| Revenue Growth | N/A | ★ 12.14 |
| 52 Week Low | $1.14 | $19.50 |
| 52 Week High | $7.20 | $34.20 |
Technical Indicators
Market Signals| Indicator | ALDX | LWAY |
|---|---|---|
| Relative Strength Index (RSI) | 50.79 | 45.09 |
| Support Level | $5.04 | $21.25 |
| Resistance Level | $5.56 | $22.27 |
| Average True Range (ATR) | 0.34 | 0.67 |
| MACD | -0.02 | 0.07 |
| Stochastic Oscillator | 27.72 | 32.12 |
Price Performance
Historical ComparisonAbout ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
About LWAY Lifeway Foods Inc.
Lifeway Foods Inc is engaged in manufacturing probiotic, cultured, functional dairy health food products. Its primary product is drinkable kefir which is a cultured dairy product. Its product categories are Drinkable Kefir which is the key revenue-driving product, European-style soft cheeses, Cream, ProBugs, Frozen Kefir and Other dairy. The company manufacture and market products under the Lifeway and Fresh Made brand names, as well as under private labels on behalf of customers. It sells the products through direct sales force, brokers, and distributors.